A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
Clinical trial NCT00002161 · COMPLETED
Trial details
- NCT number
- NCT00002161
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.